High cost and insurance restrictions are common, with many plans requiring step therapy, higher BMI, or documented inability to lose weight by other methods before approval. Do GLP-1 drugs replace the need for arthritis or autoimmune medications
The decreasing efficacy of antibiotics has put pressure on medical professionals and researchers to focus efforts on developing alternative treatments for S
The pipeline of next-generation treatments is advancing rapidly: Novo Nordisks CagriSema, a fixed-dose combination of semaglutide and the amylin analogue cagrilintide, has an FDA decision expected in late 2026 and could further accelerate the market
15 mg of tirzepatide equals 75 units at a concentration of 20 mg/mL, or 50 units at a concentration of 30 mg/mL
Retatrutide is not in the combo vial
Quick Comparison: Ozempic and Wegovy are stronger options for diabetes and weight loss, respectively